Results 181 to 190 of about 681,792 (231)
Some of the next articles are maybe not open access.

Bicyclic heterocycles as FGFR inhibitors

2021
SHVARTSBART ARTEM   +2 more
  +19 more sources

FGFR inhibitors for advanced cholangiocarcinoma

The Lancet Oncology, 2020
Tian, Yang   +3 more
openaire   +2 more sources

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

Derivatives of an FGFR inhibitor

2021
TAO MING, BOER JASON
openaire   +3 more sources

FIGHT-101, a First-in-Human Study of Potent and Selective FGFR 1-3 Inhibitor Pemigatinib in Pan-Cancer Patients With FGF/FGFR Alterations and Advanced Malignancies

Annals of Oncology, 2022
Vivek Subbiah, David C. Smith, T Ji
exaly  

Recent Advances of Dual FGFR Inhibitors as a Novel Therapy for Cancer

European Journal of Medicinal Chemistry, 2021
Jianyou Shi, Jun Hou, Yonghe Hu
exaly  

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2021
exaly  

DW14383 Is an Irreversible Pan-FGFR Inhibitor That Suppresses FGFR-Dependent Tumor Growth in Vitro and in Vivo

Acta Pharmacologica Sinica, 2021
Jing Ai, Yi-Ming Sun, Yin-Chun Ji
exaly  

TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS

2022
MCCAMMANT MATTHEW S   +4 more
openaire   +8 more sources
b2
a1
fgfr
targeted therapy
b1
fibroblast growth factor receptor
neoplasms
tumors
oncology
previous   17  18  19  20  21  

Home - About - Disclaimer - Privacy